RecruitingNot ApplicableNCT07456865
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
Sponsor
MedtronicNeuro
Enrollment
256 participants
Start Date
Mar 17, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this prospective, multicenter study is to assess the long-term safety and effectiveness of the Altaviva™ system for the treatment of UUI
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Altaviva™ system for people with urge urinary incontinence. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEAltaviva™ system
Programmable neurostimulation system that delivers electrical stimulation to the tibial nerve for tibial neuromodulation therapy.
Locations(10)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07456865